Fatal sepsis after thalidomide/dexamethasone treatment in two patients with multiple myeloma
Wölfler, A.; Bauer, F.; Zollner, G.; Weber, K.; Sill, H.; Linkesch, W.
Haematologica 88(4): Elt12
2003
ISSN/ISBN: 0390-6078 PMID: 12681989 Document Number: 559279
Document emailed within 1 workday
Related Documents
Dimopoulos, M.A.; Anagnostopoulos, A.; Terpos, E.; Repoussis, P.; Zomas, A.; Katodritou, E.; Kyrtsonis, M.Christine.; Delibasi, S.; Vassou, A.; Pouli, A.; Zervas, K.; Anagnostopoulos, N.; Maniatis, A. 2006: Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma Haematologica 91(2): 252-254Dingli, D.; Rajkumar, S.Vincent.; Nowakowski, G.S.; Gertz, M.A.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.; Fonseca, R.; Lust, J.A.; Kyle, R.A.; Greipp, P.R.; Witzig, T.E. 2005: Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial Haematologica 90(12): 1650-1654
Chou, T. 2007: Development of thalidomide analogs for the treatment of multiple myeloma (MM) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(12): 2302-2308
Boga, C.; Ozdogu, H.; Yeral, M.; Kizilkilic, E.; Tamer, L. 2007: Thalidomide in combination with dexamethasone-induced rhabdomyolysis in a patient with refractory myeloma Journal of Supportive Oncology 5(6): 256
Palumbo, A.P.; Garino, A.L.; Frieri, R.; Gallone, G.; Boccadoro, M.; Pileri, A. 1990: Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy Haematologica 75(6): 576-578
Rajkumar, S.V. 2008: Controversies regarding the use of dexamethasone in patients with multiple myeloma Clinical Advances in Hematology and Oncology: H&o 6(2): 103; 141
Dadacaridou, M.; Papanicolaou, X.; Maltesas, D.; Megalakaki, C.; Patos, P.; Panteli, K.; Repousis, P.; Mitsouli-Mentzikof, C. 2007: Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 41-44
2009: Thalidomide: new indication. For elderly myeloma patients: some improvement in first-line treatment Prescrire International 18(100): 49-52
Adam, Z.; Szturz, P.; Křen, L.; Krejčí, M.; Pour, L.; Svoboda, T.; Hanke, I.; Penka, I.; Koukalová, R.; Rehák, Z.; Cervinková, I.; Storková, T.; Král, Z.; Mayer, J. 2013: PET-CT documented fast onset of treatment response to cyclophosphamide, thalidomide and dexamethasone in patients with multicentric Castlemans disease. Case description and treatment information overview Vnitrni Lekarstvi 59(4): 301-312
Jurczyszyn, A.; Wolska-Smoleń, T.; Skotnicki, A.B. 2003: Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide Przeglad Lekarski 60(8): 542-547
Pitini, V.; Arrigo, C.; Aloi, G.; Azzarello, D.; La Gattuta, G. 2002: Diabetic foot disease in a patient with multiple myeloma receiving thalidomide Haematologica 87(2): Elt07
Aimono, Y.; Sato, W.; Otani, E.; Isa, S.; Sawahata, T.; Onozaki, M.; Saito, Y.; Ebata, S.; Aoyama, Y.; Hakozaki, M.; Suzuki, M.; Kudo, D.; Monma, Y.; Chikatsu, N.; Shinagawa, A. 2011: Reported use of thalidomide in multiple myeloma: presentation of problems in the Thaled® outpatient department Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2579-2584
Adam, Z.; Elbl, L.; Vorlícek, J.; Hájek, R.; Tomíska, M.; Hejlová, N.; Králová, E.; Novotná, H. 1994: Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD) Vnitrni Lekarstvi 40(8): 506-512
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Meregalli, M.; Bertola, G.; Grando, D. 1998: High dose dexamethasone as first line therapy of multiple myeloma? A case report Recenti Progressi in Medicina 89(1): 18-20
Facon, T. 2006: Advances in the treatment of elderly patients with multiple myeloma Clinical Advances in Hematology and Oncology: H&o 4(7): 501-502
Vulić, D.; Radlović, O.; Stanojcić, A.; Radmilović, A.; Rajić, M. 1996: Treatment of renal insufficiency in patients with multiple myeloma Srpski Arhiv Za Celokupno Lekarstvo 124(Suppl 1): 53-55
Adam, Z.; Krahulová, M.; Spelda, S.; Vorlícek, J.; Hejlová, N.; Hájek, R.; Tomíska, M. 1995: Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma Vnitrni Lekarstvi 41(11): 767-772
Clavio, M.; Casciaro, S.; Gatti, A.M.; Spriano, M.; Bonanni, F.; Poggi, A.; Vallebella, E.; Pietrasanta, D.; Prencipe, E.; Goretti, R.; Vimercati, R.; Rossi, E.; Masoudi, B.; Ghio, R.; Boccaccio, P.; Ricciardi, S.; Damasio, E.; Gobbi, M. 1996: Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients Haematologica 81(3): 238-244
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41